Logo

Clostridium difficile

With Diagenode Acquisition, Hologic Expects to Expand Panther Fusion Testing Menu
Premium

Diagenode already sells more than 30 real-time PCR tests that are CE-marked for the detection of bacteria, parasites, and viruses for multiple infectious diseases.

C. Difficile Epigenomic Analysis Uncovers Highly Conserved Methyltransferase

A group led by Mount Sinai researchers said this methyltransferase, which is involved in sporulation, could be targeted to fight infections.

ChromaCode Debuts Instrument-Agnostic Multiplex Panel for Multi-Drug Resistant Infection Screening
Premium

The firm's tick-borne pathogens panel was also recently the subject of a clinical study, showing high accuracy in detecting numerous infectious agents. 

Scope Fluidics Subsidiary Developing 15-Minute PCR System for POC Infectious Disease MDx
Premium

Based in Warsaw, Poland, the technology was inspired by "ultra-fast" PCR methods from the Wittwer group and Scope plans to launch tests for MRSA and C. diff.

Clostridium Difficile Speciation Occurring in Healthcare Settings, Genomic Study Suggests

An analysis of more than 900 C. difficile isolates uncovered four phylogenetic lineages, including three lineages in a clade showing recent positive selection on infection-related genes.

Jul 31, 2019

Meridian Bioscience Dx Revenue Woes Likely to Continue Through 2020 Despite Promising Integration of GenePOC
Premium

May 14, 2019

Mobidiag Secures €25M Loan to Build Test Menu

May 2, 2019

Meridian Biosciences Expects MDx Business Rejuvenation With GenePOC Acquisition
Premium

Nov 28, 2018

Signature Science Gets CDC Contract to Evaluate Molecular Microbial Detection Methods

Nov 28, 2018

Johns Hopkins Researchers Working on Tool to Combat C. Difficile Overtesting
Premium

Nov 15, 2018

Hospitals Build Case for Pathogen Sequencing to Track Resistance, Monitor Outbreaks
Premium

Nov 8, 2018

Meridian Bioscience Q4 Revenues Grow 7 Percent

Oct 23, 2018

GenePOC's Investment in Small Molecular Diagnostic Panels Validated by Medicare Decision, Company Says
Premium

Oct 23, 2018

GenePOC C. Diff MDx Approved in Canada

Jul 31, 2018

Meridian Bioscience Q3 Revenues Grow 3 Percent

Apr 9, 2018

Vanderbilt Applies DNA Biorepository, PheWAS to Speed Drug Repurposing Research
Premium

Feb 14, 2018

Donor, Recipient Strain Analyses Offer Fecal Transplant Engraftment Clues

Jan 12, 2018

JPM Healthcare Day Four: Natera and Luminex

Nov 28, 2017

GenePOC C. Diff Test Receives FDA Approval

Nov 27, 2017

Interlux to Distribute Mobidiag Products in Estonia

Oct 9, 2017

FDA Clears Roche C. Difficile Assay for Liat Platform

Aug 7, 2017

Luminex Q2 Revenues Up 19 Percent; Firm to Delay Verigene 2 FDA Submission

Jul 27, 2017

Meridian Bio Q3 Revenues Inch Down 1 Percent

Jul 24, 2017

Luminex Receives FDA Clearance for C. Diff Assay

May 30, 2017

MobiDiag Extends Distribution Agreement With PerkinElmer

Breaking News
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.